Amphastar Pharma (NASDAQ: AMPH) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $53.85 million versus the consensus estimate of $55.7 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.